Electronic decision support for deprescribing (MedSafer tool) for Deprescribing

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Deprescribing+2 MoreElectronic decision support for deprescribing (MedSafer tool) - Other
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the feasibility of using an electronic tool to generate real-time reports on patients' drug use, displayed to clinicians in the electronic medical record.

Eligible Conditions
  • Deprescribing
  • Adverse Drug Reactions (ADRs)
  • Overmedication

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 year

1 year
Cost savings
30-days after the prescriber receives a deprescribing report.
Proportion of patients with one or more PIM (potentially inappropriate medication) reduced or stopped
Examined at 30-days following each intervention cycle (3 cycles)
Sustainability; quality of life; sleep quality; falls; transfer to acute hospital; hip fractures; and delirium

Trial Safety

Trial Design

2 Treatment Groups

Control: Baseline (no MedSafer)
1 of 2
Intervention: MedSafer
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Electronic decision support for deprescribing (MedSafer tool) · No Placebo Group · N/A

Intervention: MedSafer
Other
Experimental Group · 1 Intervention: Electronic decision support for deprescribing (MedSafer tool) · Intervention Types: Other
Control: Baseline (no MedSafer)NoIntervention Group · 1 Intervention: Control: Baseline (no MedSafer) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

OMNI Health CareUNKNOWN
MED e-care Healthcare SolutionsUNKNOWN
Centre for Aging and Brain Health InnovationOTHER
13 Previous Clinical Trials
1,634 Total Patients Enrolled
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
399 Previous Clinical Trials
125,224 Total Patients Enrolled
1 Trials studying Deprescribing
1,000 Patients Enrolled for Deprescribing
Emily McDonald, MDCMPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Age 65+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References